9 March 2026
GENETIC PREDISPOSITIONS IN BRAIN TUMORS
It is with great pleasure that I announce the second video conference of 2026, where we will discuss Genetic Predispositions…
Category: Research
18 February 2026
VIDEO CONFERENCE “PNEI AND TUMORS: ANTI-CANCER MOLECULES IN THE HUMAN BODY”
The video conference dedicated to Psychoneuroendocrinoimmunology (PNEI) and the role of molecules produced by our body in the fight against…
GLIOBLASTOMA: NEW THERAPEUTIC FRONTIERS BETWEEN NANOTECHNOLOGY, STEM CELLS, AND THE IMMUNE SYSTEM
Next week will be packed with events to disseminate information on the treatment of glioblastoma and high-grade brain tumors. As…
PNEI AND TUMORS: THE HUMAN BODY’S ANTI-CANCER MOLECULES
It is with great pleasure that I announce the first video conference of 2026, where we will discuss Psycho-Neuro-Endocrine-Immunology (PNEI)…
MIRAGE Study: A Possible New Path for More Aggressive Meningiomas
Among tumors that develop inside the skull, meningioma is one of the most common. Unlike other brain tumors, it does not arise…
20 January 2026
Research News in the Last Two-Months of 2025
This is the thirty-fourth article of a project whose aim is to periodically collect (every two months) the latest research…
19 December 2025
NEW PHASE 3 CLINICAL TRIAL FOR GLIOBLASTOMA: OPTUNE®, TEMOZOLOMIDE, AND PEMBROLIZUMAB
Continuing with the idea of reporting to you some interesting clinical studies in the recruitment phase as we did in…
16 November 2025
RESEARCH NEWS FOR THE FIFTH BIMESTER OF 2025
This is the thirty-fourth article in the project, which aims to periodically (every two months) collect research news on potential…
TODAY WE START: THE “SPERANZA e CORAGGIO” PROJECT LAUNCHES THE ONLINE PSYCHOLOGICAL SUPPORT SERVICE FOR PATIENTS AND CAREGIVERS
We are thrilled to announce that today the operational phase of the “Speranza e Coraggio” project, the psychological support service…
GLIOBLASTOMA NAVIGATOR: THE NEW VERSION OF THE PLATFORM FOR PATIENTS, CAREGIVERS, AND SPECIALISTS IS NOW ONLINE
We are happy to announce that, after months of work and testing, the new version of the Glioblastoma Navigator platform…
